Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C5AR1 | P21730 | 2/20 | 0.59 |
| ▸ | OPRD1 | P41143 | 6/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.53 |
| ▸ | NPBWR1 | P48145 | 2/20 | 0.53 |
| ▸ | CCKAR | P32238 | 1/20 | 0.52 |
| ▸ | CCKBR | P32239 | 1/20 | 0.52 |
| ▸ | GLP1R | P43220 | 3/20 | 0.50 |
| ▸ | NPY1R | P25929 | 3/20 | 0.49 |
| ▸ | NPY2R | P49146 | 3/20 | 0.49 |
| ▸ | NPY4R | P50391 | 3/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.49 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.49 |
| ▸ | IL23R | Q5VWK5 | 3/20 | 0.48 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.48 |
| ▸ | TUBB | P07437 | 1/20 | 0.48 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.48 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.48 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.48 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.48 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL38654759 | 0.98 | C5AR1 (0.62) | C5AR1OPRD1OPRM1NPBWR1CCKAR | |
| SCHEMBL38654630 | 0.93 | C5AR1 (0.58) | C5AR1NPBWR1NPY1RNPY2RNPY4R | |
| SCHEMBL30518100 | 0.93 | C5AR1 (0.63) | C5AR1NPBWR1GLP1RIL23RTUBB4A | |
| SCHEMBL29604164 | 0.92 | C5AR1 (0.65) | C5AR1GLP1RIL23R | |
| SCHEMBL30118069 | 0.92 | C5AR1 (0.52) | C5AR1NPY1RNPY2RNPY4RTUBB4A | |
| SCHEMBL29666221 | 0.92 | C5AR1 (0.52) | C5AR1NPY1RNPY2RNPY4RTUBB4A | |
| SCHEMBL31680263 | 0.91 | C5AR1 (0.54) | C5AR1OPRD1CCKARCCKBRGLP1R | |
| SCHEMBL30518049 | 0.91 | C5AR1 (0.53) | C5AR1OPRD1OPRM1NPBWR1GLP1R | |
| SCHEMBL31680253 | 0.91 | C5AR1 (0.61) | C5AR1NPBWR1NPY1RNPY2RNPY4R | |
| SCHEMBL31091318 | 0.90 | C5AR1 (0.48) | C5AR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078144-A1 | ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF | WINKEY TECH USA INC (US) | 2026-03-19 | — | — | US | claimed |
| WO-2024217503-A1 | ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF | 深圳市维琪科技股份有限公司 | 2024-10-24 | — | — | WO | claimed |
| CN-116535463-A | Active peptide, composition and use thereof | 深圳市维琪科技股份有限公司 | 2023-08-04 | — | — | CN | claimed |
| US-20260078144-A1 | ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF | WINKEY TECH USA INC (US) | 2026-03-19 | — | — | US | disclosed |
| WO-2024217503-A1 | ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF | 深圳市维琪科技股份有限公司 | 2024-10-24 | — | — | WO | disclosed |
| CN-117343140-B | Active peptide, composition and use thereof | 深圳市维琪科技股份有限公司 | 2024-09-20 | — | — | CN | disclosed |
| CN-117343140-A | Active peptide, composition and use thereof | 深圳市维琪科技股份有限公司 | 2024-01-05 | — | — | CN | disclosed |
| CN-116535463-B | Active peptide, composition and use thereof | 深圳市维琪科技股份有限公司 | 2023-10-31 | — | — | CN | disclosed |
| CN-116535463-A | Active peptide, composition and use thereof | 深圳市维琪科技股份有限公司 | 2023-08-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078144-A1 | ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF | ARGLU1, ARG1, POT1 | C5AR1 1713/4885OPRD1 2707/4885OPRM1 1612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.